Boyd Consultants has appointed Céline Courtay-Cahen as a regulatory affairs consultant, based out of its Cambridge, UK office.
In her new role, Courtay-Cahen will manage projects including orphan drug designations, clinical trial applications and marketing authorisation applications.
She joins the consultancy from Evigo Pharma Consulting, where she also served as a regulatory affairs consultant and worked on a number of gene therapy projects, paediatric products, and in pharmacovigilance.
Prior to this, Courtay-Cahen worked in a various research positions with roles at the Institute of Structural Biology in Grenoble, the faculty of medicine at the Free University of Brussels, and the department of pathology at the University of Cambridge.
Alan Boyd, founder and chief executive officer of Boyd Consultants, said: “I am delighted to welcome Céline to our team at this exciting time. Her expertise will complement that of the team adding more value to our clients.”